Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine.
Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.
News
Can entrepreneurship rescue the U.S.? (interview)
November 22, 2012 4:00 pm
July 9-10, 2013 San Francisco, CA Tickets On Sale Now It’s no secret that the U.S. economy is in a… Continue reading ⟩
Harvard’s ‘wise men’ tell Silicon Valley: Our country is losing its competitiveness
September 11, 2012 3:00 pm
A trio of Harvard Business School professors made a stop in Silicon Valley to warn that the economic competitiveness of… Continue reading ⟩
If Facebook were an online stock brokerage, it would look like Motif
June 4, 2012 6:39 pm
Take one helping of Facebook: social, status updates, friends, and games. Add any online brokerage: stocks, money, charts, and choices.… Continue reading ⟩